Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Gland Pharma has informed about schedule of the Analyst/ Institutional Investor Meeting with Max Life Insurance Company on 17th March 2023.
The above information is a part of company’s filings submitted to BSE.